Cargando…

Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy

BACKGROUND: Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing. CASES SUMMARY: We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Aouate, David, Menet, Aymeric, Bellevre, Dimitri, Damy, Thibaud, Marechaux, Sylvestre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319833/
https://www.ncbi.nlm.nih.gov/pubmed/32617488
http://dx.doi.org/10.1093/ehjcr/ytaa088
_version_ 1783551127558553600
author Aouate, David
Menet, Aymeric
Bellevre, Dimitri
Damy, Thibaud
Marechaux, Sylvestre
author_facet Aouate, David
Menet, Aymeric
Bellevre, Dimitri
Damy, Thibaud
Marechaux, Sylvestre
author_sort Aouate, David
collection PubMed
description BACKGROUND: Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing. CASES SUMMARY: We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart failure and depressed left ventricular ejection fraction (LVEF) following permanent right ventricular (RV) pacing but highly responded to cardiac resynchronization therapy (CRT). DISCUSSION: The impact of RV pacing and CRT in cardiac amyloidosis is not known. In our cases, the detrimental effect of permanent RV pacing on left ventricular (LV) systolic function and heart failure symptoms was suggested by both permanent RV pacing mediated functional and LV function decline and LV systolic dysfunction reversal following CRT along with QRS width reduction. Whether cardiac resynchronization should be readily recommended in ATTR patients who need ventricular pacing whatever the LVEF deserves further investigation.
format Online
Article
Text
id pubmed-7319833
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-73198332020-07-01 Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy Aouate, David Menet, Aymeric Bellevre, Dimitri Damy, Thibaud Marechaux, Sylvestre Eur Heart J Case Rep Case Series BACKGROUND: Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing. CASES SUMMARY: We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart failure and depressed left ventricular ejection fraction (LVEF) following permanent right ventricular (RV) pacing but highly responded to cardiac resynchronization therapy (CRT). DISCUSSION: The impact of RV pacing and CRT in cardiac amyloidosis is not known. In our cases, the detrimental effect of permanent RV pacing on left ventricular (LV) systolic function and heart failure symptoms was suggested by both permanent RV pacing mediated functional and LV function decline and LV systolic dysfunction reversal following CRT along with QRS width reduction. Whether cardiac resynchronization should be readily recommended in ATTR patients who need ventricular pacing whatever the LVEF deserves further investigation. Oxford University Press 2020-05-01 /pmc/articles/PMC7319833/ /pubmed/32617488 http://dx.doi.org/10.1093/ehjcr/ytaa088 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Series
Aouate, David
Menet, Aymeric
Bellevre, Dimitri
Damy, Thibaud
Marechaux, Sylvestre
Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
title Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
title_full Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
title_fullStr Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
title_full_unstemmed Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
title_short Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
title_sort deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319833/
https://www.ncbi.nlm.nih.gov/pubmed/32617488
http://dx.doi.org/10.1093/ehjcr/ytaa088
work_keys_str_mv AT aouatedavid deleteriouseffectofrightventricularpacinginpatientswithcardiactransthyretinamyloidosispotentialclinicalbenefitofcardiacresynchronizationtherapy
AT menetaymeric deleteriouseffectofrightventricularpacinginpatientswithcardiactransthyretinamyloidosispotentialclinicalbenefitofcardiacresynchronizationtherapy
AT bellevredimitri deleteriouseffectofrightventricularpacinginpatientswithcardiactransthyretinamyloidosispotentialclinicalbenefitofcardiacresynchronizationtherapy
AT damythibaud deleteriouseffectofrightventricularpacinginpatientswithcardiactransthyretinamyloidosispotentialclinicalbenefitofcardiacresynchronizationtherapy
AT marechauxsylvestre deleteriouseffectofrightventricularpacinginpatientswithcardiactransthyretinamyloidosispotentialclinicalbenefitofcardiacresynchronizationtherapy